ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,605, issued on Nov. 25, was assigned to UNIVERSITAT REGENSBURG (Regensburg, Germany).
"Biochanin a derivatives for treatment of BEST1-related retinopathies" was invented by Bernhard Weber (Obertraubling, Germany), Andrea Milenkovic (Kofering, Germany), Sabine Amslinger (Aschheim, Germany) and Lisa Marie Durr (Regensburg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to Biochanin A derivative as defined in formula (II) or a salt thereof for use in a method of treating or preventing BEST1-related retinopathies such as autosomal dominant Best vitelliform macular dystrophy. The present invention also refers to a pha...